# Influence of Progesterone Administration on Drug-Induced QT Interval Lengthening

> **NCT01929083** · PHASE2 · COMPLETED · sponsor: **Indiana University** · enrollment: 19 (actual)

## Conditions studied

- Prolonged QT Interval in EKG and Sudden Death

## Interventions

- **DRUG:** Progesterone
- **DRUG:** Placebo
- **DRUG:** Ibutilide

## Key facts

- **NCT ID:** NCT01929083
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2015-10-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01929083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01929083, "Influence of Progesterone Administration on Drug-Induced QT Interval Lengthening". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01929083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*